CN103740816B - The Primer composition that a kind of ox citrullinemia deleterious gene detects and test kit thereof and application - Google Patents
The Primer composition that a kind of ox citrullinemia deleterious gene detects and test kit thereof and application Download PDFInfo
- Publication number
- CN103740816B CN103740816B CN201310708022.9A CN201310708022A CN103740816B CN 103740816 B CN103740816 B CN 103740816B CN 201310708022 A CN201310708022 A CN 201310708022A CN 103740816 B CN103740816 B CN 103740816B
- Authority
- CN
- China
- Prior art keywords
- primer
- citrullinemia
- test kit
- deleterious gene
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010058298 Argininosuccinate synthetase deficiency Diseases 0.000 title claims abstract description 64
- 201000011297 Citrullinemia Diseases 0.000 title claims abstract description 64
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 43
- 230000002939 deleterious effect Effects 0.000 title claims abstract description 36
- 239000000203 mixture Substances 0.000 title claims abstract description 32
- 238000012360 testing method Methods 0.000 title claims abstract description 28
- 238000001514 detection method Methods 0.000 claims abstract description 19
- 239000002773 nucleotide Substances 0.000 claims abstract description 3
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 3
- 108700024106 Argininosuccinate synthases Proteins 0.000 claims description 9
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 5
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 5
- 150000001413 amino acids Chemical class 0.000 claims description 5
- 239000011535 reaction buffer Substances 0.000 claims description 5
- 108020004485 Nonsense Codon Proteins 0.000 claims description 3
- 230000037434 nonsense mutation Effects 0.000 claims description 3
- 238000000034 method Methods 0.000 abstract description 21
- 241000283690 Bos taurus Species 0.000 abstract description 17
- 230000003321 amplification Effects 0.000 abstract description 13
- 238000003199 nucleic acid amplification method Methods 0.000 abstract description 13
- 210000004369 blood Anatomy 0.000 abstract description 12
- 239000008280 blood Substances 0.000 abstract description 12
- 230000000869 mutational effect Effects 0.000 abstract description 10
- 230000008859 change Effects 0.000 abstract description 9
- 238000007857 nested PCR Methods 0.000 abstract description 7
- 238000000605 extraction Methods 0.000 abstract description 6
- 238000012163 sequencing technique Methods 0.000 abstract description 6
- 108020004414 DNA Proteins 0.000 description 24
- 238000006243 chemical reaction Methods 0.000 description 22
- 230000007547 defect Effects 0.000 description 11
- 239000000872 buffer Substances 0.000 description 10
- 239000003153 chemical reaction reagent Substances 0.000 description 10
- 102000004190 Enzymes Human genes 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 9
- 238000013461 design Methods 0.000 description 8
- 239000013612 plasmid Substances 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 235000013336 milk Nutrition 0.000 description 7
- 239000008267 milk Substances 0.000 description 7
- 210000004080 milk Anatomy 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 108010002747 Pfu DNA polymerase Proteins 0.000 description 6
- 101150073635 Ass gene Proteins 0.000 description 5
- 230000001627 detrimental effect Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 102000053640 Argininosuccinate synthases Human genes 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 3
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 3
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 3
- 238000009004 PCR Kit Methods 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 101150044072 cn gene Proteins 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 229960003104 ornithine Drugs 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 108700028369 Alleles Proteins 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- 102100020999 Argininosuccinate synthase Human genes 0.000 description 2
- 208000031404 Chromosome Aberrations Diseases 0.000 description 2
- 238000007400 DNA extraction Methods 0.000 description 2
- 208000027219 Deficiency disease Diseases 0.000 description 2
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 2
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 2
- 239000012807 PCR reagent Substances 0.000 description 2
- 238000011529 RT qPCR Methods 0.000 description 2
- CGNLCCVKSWNSDG-UHFFFAOYSA-N SYBR Green I Chemical compound CN(C)CCCN(CCC)C1=CC(C=C2N(C3=CC=CC=C3S2)C)=C2C=CC=CC2=[N+]1C1=CC=CC=C1 CGNLCCVKSWNSDG-UHFFFAOYSA-N 0.000 description 2
- 208000028250 allosomal inheritance Diseases 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 208000028281 autosomal inheritance Diseases 0.000 description 2
- 230000002902 bimodal effect Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 231100000005 chromosome aberration Toxicity 0.000 description 2
- 229960002173 citrulline Drugs 0.000 description 2
- 235000013477 citrulline Nutrition 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- ZFGMDIBRIDKWMY-PASTXAENSA-N heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 description 2
- 229960001008 heparin sodium Drugs 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- 230000008676 import Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 210000004731 jugular vein Anatomy 0.000 description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 208000028284 monogenic inheritance Diseases 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 241000283725 Bos Species 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 101150060155 Dcc gene Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 206010017577 Gait disturbance Diseases 0.000 description 1
- 206010020575 Hyperammonaemia Diseases 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- 238000001190 Q-PCR Methods 0.000 description 1
- 108020005038 Terminator Codon Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- KDZOASGQNOPSCU-UHFFFAOYSA-N argininosuccinate Chemical compound OC(=O)C(N)CCCN=C(N)NC(C(O)=O)CC(O)=O KDZOASGQNOPSCU-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 230000009027 insemination Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 208000028280 polygenic inheritance Diseases 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000004153 renaturation Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 206010048282 zoonosis Diseases 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6848—Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses Primer composition and test kit and application that a kind of ox citrullinemia deleterious gene detects.Primer composition of the present invention is made up of primer sets A and primer sets B, and described primer sets A is made up of primer 1 and primer 2, and described primer sets B is made up of primer 3 and primer 4; The nucleotide sequence of primer 1 ~ primer 4 is respectively as shown in SEQ ID NO.1 ~ 4.Present invention also offers the test kit comprising described combination of primers, the method that test kit of the present invention is applied to the detection of ox citrullinemia deleterious gene is as follows: complete group of DNA in extraction bovine blood is as template, carry out nest-type PRC (Nested PCR) amplification, gained PCR primer checks order, the base change in mutational site can be directly acquainted with according to sequencing result, ensure that the accuracy of result, meet fast, precisely, the demand of the detection technique of the feature such as high-throughput.
Description
Technical field
The present invention relates to biological technical field.More specifically, Primer composition and test kit and application that a kind of ox citrullinemia deleterious gene detects is related to.
Background technology
Along with the promotion and application of artificial insemination and embryo transfer technology, milk cow outstanding kind of matter (embryo, seminal fluid, kind ox) widespread use in the world, while significantly improving heritability, accelerates the harm of ox recessive genetic disorder to cows.Particularly an outstanding breeding oxen can produce hundreds of thousands of agent even up to a million doses of frozen semens all one's life, if carry recessive inheritance dcc gene, likely spreads fast in worldwide, brings huge financial loss to the production of livestock industry.China is mainly from a large amount of milk cow of state's import outstanding kind of matter such as the U.S., Canada, Germany, Australia, New Zealand and Uruguays, during import, quarantine focuses on preventing importing into of zoonosis and parasitosis, but the quarantine request preventing ox hereditary defect is not comprised, so the ox hereditary defect carrier existed enters the risk of China.
Genetic deficiency diseases is that genetic material producer sudden change in sexual cell or zygote and chromosome aberration cause; thus make growth individuality occur the exception in anatomical structure or the infringement on physiological function; usually cause the infringement of some organ; form deformity; affect production performance, even cause death.There is congenital and feature that is familial.Hereditary defect venereal disease is divided into autosomal inheritance defect disease and allosomal inheritance defect disease, wherein autosomal inheritance defect old complaint is divided into again monogenic inheritance defect disease, polygenic inheritance defect disease and chromosome aberration genetic deficiency diseases three kinds according to pathogenesis, and allosomal inheritance defect is more rare.Euchromosome monogenic inheritance defect disease is controlled by pair of alleles, and recessive deleterious alleles carrier phenotype is normal, when two parents are carrier, offspring has 1/4 may occur allozygote, namely phenotype is ill, and 1/2 may be recessive heterozygote, is deleterious gene carrier.
Citrullinemia (Citrullinemia, CN) is that a kind of euchromosome single-gene recessive inheritance defect of Holstein cow ornithine cycle generation metabolism disorder is sick.This disease found (Harper etc., 1986) early than 1986 in the Holstein cow group of Australia.Act normally during sick ox birth, but occur that spirit is depressed in the near future, gait disturbance, convulsions, the symptom such as blind, after general birth, 5 d are dead, mortality ratio 100%.Citrullinemia (CN) genetic base is by ASS gene (the Argininosuccinate synthetase of the encode arginine succsinic acid synthetic enzyme on milk cow o.11 karyomit(e) (BTA11), ASS) there is the point mutation of C → T in the 5th exon, codon CGA is made to change terminator codon TGA into, thus its translation product argininosuccinate synthase becomes 85 amino acid whose protein (being normally 412 amino acid) of brachymemma, and lose argininosuccinate synthase activity.Cause citrulline can not change argininosuccinate acid into and put aside in a large number in tissue and blood, thus cause ornithine cycle generation metabolic disturbance, and then cause serum amylase too high.Ill ox cardinal symptom is that in blood, citrulline content raises, and ornithine cycle is obstructed and is caused hyperammonemia, causes birth interior death in latter one week.
According to this mutational site, mainly contain PCR-RFLP and AS-PCR two kinds of methods at present and detect citrullinemia (CN).PCR-RFLP method designs at catastrophe point place
avaIIrestriction enzyme site, carries out enzyme to PCR primer and cuts, and cuts result judge whether to have according to enzyme
avaIIrestriction enzyme site is in order to judge whether containing catastrophe point, but after the method introducing base mismatch, the amplification efficiency of PCR can be affected, and there is false-positive possibility in addition.AS-PCR method designs special primer according to mutational site, wherein a kind of base state in a chain and mutational site is complementary, another chain designs according to a conventional method, special primer has amplified production in a kind of genotype, amplified production is not had in another kind of genotype, according to the presence or absence that amplification is produced, thus determine whether the sudden change of base, but the method cause sometimes when the base of the 3' end of primer and the base of template not complementary, extend and still can carry out, easily cause the erroneous judgement of result.
Summary of the invention
The technical problem to be solved in the present invention overcomes the deficiency that existing ox citrullinemia deleterious gene detects detection technique, provides the Primer composition that a kind of ox citrullinemia deleterious gene detects.
Another technical problem that the present invention will solve is to provide the test kit that a kind of ox citrullinemia deleterious gene detects.
The present invention also has a technical problem that will solve to be to provide the application of described Primer composition and test kit.
Above-mentioned purpose of the present invention is achieved through the following technical solutions:
The invention provides a kind of new Primer composition, be the Primer composition that ox citrullinemia deleterious gene detects, be made up of primer sets A or primer sets B; Described primer sets A is made up of primer 1 and primer 2; Described primer sets B is made up of primer 3 and primer 4; The nucleotide sequence of primer 1 ~ 4 is respectively as shown in SEQ ID NO.1 ~ 4.
Described primer sets A is outer primer, and primer sets B is inner primer, and inner primer designs in the fragment of external primer amplification.
Preferably, described ox citrullinemia deleterious gene is the gene of the 86th amino acid codes generation nonsense mutation of argininosuccinate synthase gene.
Preferably, the mol ratio of primer 1 and primer 2 is 1: 1, and the mol ratio of primer 3 and primer 4 is 1: 1.
The invention provides the application of Primer composition in employing nested PCR method detection ox citrullinemia deleterious gene that described ox citrullinemia deleterious gene detects.
The present invention provides a kind of test kit of the Primer composition containing described ox citrullinemia deleterious gene detection simultaneously.
In described test kit, preferably, described primer sets A or primer sets B is complete independent packaging.
Preferably, described test kit, includes following component: the Primer composition that ox citrullinemia deleterious gene of the present invention detects, archaeal dna polymerase, PCR reaction buffer, dNTP and aqua sterilisa.
Preferably, the Primer composition that described test kit detects except comprising described ox citrullinemia deleterious gene, also includes Pfu DNA Polymerase enzyme (2.5U/ul) and 10 × Pfu Buffer, dNTP Mixture(2.5 mmol/L), and ddH
20.
The present invention provides described test kit detecting the application in ox citrullinemia deleterious gene simultaneously.
Ox citrullinemia deleterious gene detection method of the present invention utilizes nested PCR method to carry out twice PCR reaction, and the template of first time PCR reaction is complete group of DNA in bovine blood, and primer is primer sets A; The template of second time PCR reaction is the diluent (sterilized water dilution) of first time PCR reaction product, and primer is primer sets B; PCR primer is checked order, detects ox citrullinemia deleterious gene according to sequencing result.
Preferably, described first time PCR reacts the fragment that amplification obtains a 420bp of argininosuccinate synthase gene, as shown in SEQ ID NO.5; Second time PCR reaction amplification obtains the fragment of a 162bp of argininosuccinate synthase gene, as shown in SEQ ID NO.6; Detecting ox citrullinemia deleterious gene concrete grammar according to sequencing result is check whether the 86th amino acid codes of argininosuccinate synthase gene nonsense mutation occurs according to sequencer map.If this site is unimodal C in sequencer map, then it is non-citrullinemia deleterious gene; This site is bimodal, simultaneously containing C and T, is then ox citrullinemia deleterious gene; This site is unimodal T, be then ox citrullinemia patient.
Preferably, the ratio of each component in the amplification system that reacts of described first time PCR: primer 1: primer 2: PCR reaction buffer: dNTP: archaeal dna polymerase: aqua sterilisa=2: 2: 10: 10: 1: 73;
Preferably, the ratio of each component in the amplification system of second time PCR reaction: primer 3: primer 4: PCR reaction buffer: dNTP: archaeal dna polymerase: aqua sterilisa=2: 2: 10: 10: 1: 73.
The present invention has following beneficial effect:
The Primer composition that scientific design of the present invention a group is new, have excellent specific amplification, amplification efficiency is high, effectively avoids false-negative result, is applied to detection ox citrullinemia (CN) deleterious gene accuracy high.
Invention also provides and detect ox citrullinemia (CN) detrimental method, creatively study the gene of ox, the feature larger according to the genome of ox, sum up the nested PCR detection method of twice, by twice PCR, avoid prior art only by a PCR, due to the concentration of DNA profiling and the relation of purity, amplification efficiency is not high, and the problem of the fragment that easily makes a mistake.And second time PCR reaction occurs that the probability that primer pairing is also increased in false segments is extremely low.
The judgement of net result of the present invention is undertaken by order-checking, directly can measure the base change in mutational site, further ensure that the accuracy of result.
Instant invention overcomes the troublesome operation such as the gel electrophoresis required for prior art, the present invention has quick, accurate, high-throughout advantage, provide strong technical foundation for detecting ox citrullinemia (CN) deleterious gene, and be specially adapted in foreign trade the detrimental detection technique demand of ox citrullinemia (CN).
Accompanying drawing explanation
Fig. 1 is non-citrullinemia deleterious gene carrier (normal type) milk cow ASS gene sequencing figure, and arrow place is mutational site.
Fig. 2 is citrullinemia deleterious gene carrier milk cow ASS gene sequencing figure, and arrow place is mutational site.
Fig. 3 is the HRM temperature variation of CN gene homogenization.
Fig. 4 is the HRM difference view of CN gene.
Embodiment
Further illustrate the present invention below in conjunction with the drawings and specific embodiments, but embodiment does not limit in any form to the present invention.Unless stated otherwise, the present invention adopts reagent, equipment and method are the art conventional reagent, equipment and method.
Embodiment of the present invention Pfu DNA used Polymerase enzyme (2.5U/ul) and 10 × Pfu Buffer, dNTP Mixture (2.5 mmol/L), all purchased from Tian Gen bio tech ltd.
embodiment 1 prepares the nest-type PRC reaction kit of examination ox citrullinemia
1, design of primers
Constantly analyze, sum up and adjust the design of primer in conjunction with Integral Thought of the present invention according to ASS gene order (GenBank:AC_000168) on NCBI, finally according to ASS gene (the Argininosuccinate synthetase of the encode arginine succsinic acid synthetic enzyme on ox o.11 karyomit(e) (BTA11), ASS) there is the point mutation of C → T in the 5th exon, devise the detrimental nested PCR method of a kind of detection ox citrullinemia, obtain primer 1, primer 2, primer 3 and primer 4.Sequence is as shown in SEQ ID NO.1 ~ 4:
Primer 1:SEQ ID NO.1:actgcatttt caagaccacc ctg;
Primer 2: SEQ ID NO.2:tctgggcggg aaccaacgat tgtc;
Primer 3:SEQ ID NO.3:attgaggaca tcagcaagga g;
Primer 4:SEQ ID NO.4:cacatacttg gctccttctc.
Wherein, primer 1 and primer 2 are primer sets A(outer primer), primer 3 and primer 4 are primer sets B(inner primer).
All primers can adopt the ordinary methods such as synthesis to obtain.The present embodiment primer is synthesized by Shanghai Ying Jun Bioisystech Co., Ltd.
Test kit is become with primer sets of the present invention reagent set relevant with PCR reaction.Described primer sets is primer sets A and primer sets B; It is archaeal dna polymerase, PCR reaction buffer, dNTP and aqua sterilisa that described PCR reacts related reagent.
The present embodiment uses (nest-type PRC reaction kit) for primer sets A and primer sets B simultaneously, and the preparation detecting the detrimental test kit of ox citrullinemia is described.
2, the nest-type PRC reaction kit that prepared by the present embodiment comprises two parts: first time PCR(outer primer) test kit and second time PCR(inner primer) test kit.
(1) first time PCR(outer primer) test kit
Test kit, except comprising outer primer (primer 1 and primer 2), also comprises PCR reaction reagent: Pfu DNA Polymerase enzyme (2.5U/ul), 10 × Pfu Buffer, dNTP Mixture(2.5 mmol/L), ddH
20.The primer 1 of PCR reaction is forward primer, and primer 2 is reverse primer, and forward and reverse primer concentration is 10pmol/L.
PCR reaction system is for 25 uL systems: primer 1 and each 0.5mL of primer 2,10 × Pfu Buffer 2.5mL, dNTP Mixture(2.5 mmol/L) 2.5mL, Pfu DNA Polymerase enzyme (2.5U/ul) 0.25mL, ddH
20 18.25mL, remaining 0.5mL volume is template DNA.Namely for each component proportions in the reagent mixed liquor of first time PCR reaction be, primer 1: primer 2: 10 × Pfu Buffer: dNTP Mixture: Pfu DNA Polymerase enzyme: ddH
20=2: 2: 10: 10: 1: 73.
Add Related Component in proportion according to the total amount of system during experiment and mix, adding template DNA and carry out first time PCR and react.
(2) second time PCR(inner primer) test kit:
Test kit comprises outer primer (primer 3 and primer 4), and the primer 3 of PCR reaction is forward primer, and primer 4 is reverse primer, and forward and reverse primer concentration is 10pmol/L.Except primer, other Related Components are identical with first time PCR kit with the ratio of each composition.I.e. primer 3: primer 4: 10 × Pfu Buffer: dNTP Mixture: Pfu DNA Polymerase enzyme: ddH20=2: 2: 10: 10: 1: 73.
Add Related Component in proportion according to the total amount of system during experiment and mix, to add template DNA carrying out second time PCR reaction.
the nest-type PRC reaction kit that embodiment 2 utilizes embodiment 1 to prepare detects milk cow citrullinemia
1, the full extraction organizing DNA in bovine blood
The blood sample 5mL/ head of jugular vein blood collection method random acquisition Jiangsu isolation camp 243 holstein cows, and be placed in vacuum heparin sodium anticoagulant tube and shake up rear centrifuge tube packing often pipe 2ml ,-20 DEG C are frozen for subsequent use.
Adopt Promega Maxwell 16 nucleic acid automatic extracting instrument to carry out the extraction of poba gene group DNA, use matched reagent box (AS1010 of Promega company).The AS1010 test kit of Promega comprises Maxwell 16 Blood DNA Cartridges, Purification Plungers, Elution Tubes, Elution buffer.Operation is undertaken by test kit specification sheets, and after this instrument starts, approximately every 28min can complete the extraction of 16 sample DNAs.After DNA extraction, it be transferred to from wash-out pipe in centrifuge tube (Ep pipe), it is stand-by to be placed in-20 DEG C of preservations.
Through measuring, the concentration that the bovine blood of extraction organizes DNA sample is entirely 83ng/ μ L.
2, first time PCR(outer primer) reaction
The DNA obtained with above-mentioned extracting is template, increases by the first time PCR kit in embodiment 1.System is 25 μ L: template DNA 0.5mL(41.5 ng), first time PCR reagent mixture 24.5mL(is comprising primer 1 and each 0.5mL of primer 2,10 × Pfu Buffer 2.5mL, dNTP Mixture(2.5 mmol/L) 2.5mL, Pfu DNA Polymerase enzyme (2.5U/ul) 0.25mL, ddH
20 18.25mL).Amplification condition is: 94 DEG C of 3min, 94 DEG C of 30s, 62.2 DEG C of 30s, 70 DEG C of 15s, 30cycles, 70 DEG C of 1min.
Be that template is as negative control with sterilized water.
3, second time PCR(inner primer) reaction
Get 5mL first time PCR primer and dilute 100 times as the template of second time PCR reaction, increase by the second time PCR kit in embodiment 1.System is 50 μ L: template DNA 1mL, second time PCR reagent mixture 49mL.Amplification condition is: 94 DEG C of 3min, 94 DEG C of 30s, 61.2 DEG C of 30s, 70.4 DEG C of 15s, 30 cycles, 70.4 DEG C of 1min.
4, check order (check order completed) by the prosperous bio tech ltd of Beijing AudioCodes to first time PCR and second time PCR primer respectively, the sequencing result DNAMAN software analysis of amplified production, in accompanying drawing, arrow institute mark point is the SNP site causing CN.Check whether ox citrullinemia deleterious gene carrier mutational site changes according to sequencer map, if in sequencer map this site be unimodal C(as shown in Figure 1, arrow place is mutational site), be then non-citrullinemia deleterious gene carrier (normal type); If this site is bimodal, as shown in Figure 2 containing C and T(, arrow place is mutational site simultaneously), be then citrullinemia deleterious gene carrier (heterozygote); If this site is unimodal T, be then citrullinemia patient (saltant type does not find this type of in examination).
Statistical result showed, in 243 increment product, CN normal type 238 parts, CN heterozygote 5 parts, CN saltant type 0 part.
comparative example 1 utilizes HRM detection method to detect milk cow citrullinemia
1, material
(1) test sample: with embodiment 2, the blood sample 5ml/ head of jugular vein blood collection method random acquisition Jiangsu isolation camp 243 holstein cows, and be placed in vacuum heparin sodium anticoagulant tube and shake up rear centrifuge tube packing often pipe 2ml ,-20 DEG C are frozen for subsequent use.
DNA extraction method is with embodiment 2.
(2) reagent and test kit
General T aq enzyme reagent kit, purchased from water source biotechnology (Shanghai) Co., Ltd.;
Gel extraction kit, purchased from JaRa bio tech ltd, Shanghai;
100 bp DNA Ladder Marker, purchased from water source biotechnology (Shanghai) Co., Ltd.;
Hot start Taq enzyme reagent kit, purchased from water source biotechnology (Shanghai) Co., Ltd.;
EverGreen Q-PCR Mix, purchased from water source biotechnology (Shanghai) Co., Ltd.;
T-carrier, purchased from precious biological (Dalian) biotechnology company limited;
SYBR GREEN I, purchased from Pu Boxin bio tech ltd, Beijing.
(3) preparation of main agents
Electrophoretic buffer (50 × TAE stock solution): take Tris 242g, glacial acetic acid 57.1mL, adds 100mL 0.5mol/L EDTA solution (pH8.0), is settled to 1L, with front with distilled water diluting for 1 × working fluid.
SYBR Green I dyestuff (electrophoresis level) working fluid: by the proportional arrangement of 1:3, gets TAE electrophoresis working buffer liquid and SYBR Green I dyestuff.
2, the structure of standard plasmid
Adopt the method for full genome synthesis (being synthesized by JaRa bio tech ltd, Shanghai), build CN standard substance, mutated-genotype plasmid (T/T type), wild-type genotype plasmid (G/G type), then make heterozygous genes masterplate (G/T type) with the mixing of the two equal proportion.
3, the Design and synthesis of HRM primer
According to the CN sequence that Genbank has delivered, the primer of application DNAstar software design specific PCR.Primer is synthesized by JaRa bio tech ltd, Shanghai.Concrete primer is as follows:
F1:5’- AAGGAGTTTGTGGAGGAGTTCATC-3’;
R1: 5’-GAGAGGTGCCCAGGAGGTATC-3’。
The product size of primer is 82bp, and annealing temperature is 60 DEG C.
4, the preliminary foundation of HRM detection method
The genotypic defining method of the blood sample DNA of (1) 243 holstein cow is, the tracing pattern of reference standard plasmid is determined.
(2) homozygosity and the mixing plasmid DNA of getting the wild of each standard plasmid of 1 μ L and sudden change do template respectively, carry out pcr amplification according to following system.PCR system is 30 μ L, comprises the ddH of 2 × Mix buffer of 15 μ L, the dNTP of 5 μ L, each 0.5 μ L of upstream and downstream primer, 1 μ L template DNA, 13 μ L
2o.
Reaction conditions is 94 DEG C of denaturation 3min, 94 DEG C of sex change 30s, and 60 DEG C of annealing 30s, 72 DEG C extend 30s, and 40 circulations, react and carry out on Roche480 quantitative real time PCR Instrument, carry out HRM analysis after reaction terminates.HRM analyzes and adopts Roche480 quantitative real time PCR Instrument, and testing conditions is 95 DEG C of sex change 1min, 40 DEG C of renaturation 1min, 50 DEG C keep 10s, from 50 DEG C, gather melting curve data with 0.01 DEG C/s heat-up rate, collection 40 secondary data per second, terminates fluorescent collecting to 95 DEG C.
5, data analysis
The HRM analysis software adopting Roche 480 to carry is analyzed.First homogenization (normalization) is carried out to original melting curve, software can divide into groups to curve type automatically, the sample with identical or close tracing pattern will be classified as one group, then be showed the result of grouping by the differential display function of software.With the same sample organized of known standard plasmid, namely there is the genotype of this plasmid gene type.
Result as shown in accompanying drawing 3 and accompanying drawing 4, the two obvious difference of the normal type (T/T) of CN gene and saltant type (C/C).
Statistical result showed, in 243 increment product, CN normal type 238 parts, CN heterozygote 5 parts, CN saltant type 0 part.
The result that result and nested PCR method of the present invention combine the detection method gained checked order is consistent.
In sum, it is simple, easy to operate that the present invention utilizes nested PCR method to combine the detrimental method of order-checking detection ox citrullinemia, and accuracy is high, is applicable to the needs of quick, accurate, high-throughout detection technique.
SEQUENCE LISTING
<110> Agricultural University Of South China
The Primer composition that a <120> ox citrullinemia deleterious gene detects and test kit thereof and application
<130>
<160> 6
<170> PatentIn version 3.3
<210> 1
<211> 23
<212> DNA
<213> first time PCR upstream primer sequence
<400> 1
actgcatttt caagaccacc ctg 23
<210> 2
<211> 24
<212> DNA
<213> first time PCR downstream primer sequence
<400> 2
tctgggcggg aaccaacgat tgtc 24
<210> 3
<211> 21
<212> DNA
<213> second time PCR upstream primer sequence
<400> 3
attgaggaca tcagcaagga g 21
<210> 4
<211> 20
<212> DNA
<213> second time PCR downstream primer sequence
<400> 4
cacatacttg gctccttctc 20
<210> 5
<211> 420
<212> DNA
<213> first time PCR primer sequence
<400> 5
actgcatttt caagaccacc ctgttagctg cgtctgcctt agacacaggc catcggagac 60
tctgtcttct gacggtgccc tgtccttgcc aaggctccct cccatgggct gctctcccac 120
aggtgttcat tgaggacatc agcaaggagt ttgtggagga gttcatctgg ccggccatcc 180
agtccagcgc actgtacgag gaccgatacc tcctgggcac ctctctcgcc aggccctgca 240
tcgcccgcaa gcaggtggag atcgcccagc gagaaggagc caagtatgtg tctcacggcg 300
ccacaggaaa ggtgaggcca gcatgtgtgg ctggagaggg tgaggagggg ggctgccagg 360
gggaagtggg cagcggggcc tgatgggcgg tcctcggaca atcgttggtt cccgcccaga 420
<210> 6
<211> 162
<212> DNA
<213> second time PCR primer sequence
<400> 6
attgaggaca tcagcaagga gtttgtggag gagttcatct ggccggccat ccagtccagc 60
gcactgtacg aggaccgata cctcctgggc acctctctcg ccaggccctg catcgcccgc 120
aagcaggtgg agatcgccca gcgagaagga gccaagtatg tg 162
Claims (4)
1. a Primer composition for ox citrullinemia deleterious gene detection, is characterized in that, be made up of primer sets A and primer sets B; Described primer sets A is made up of primer 1 and primer 2; Described primer sets B is made up of primer 3 and primer 4; The nucleotide sequence of primer 1 ~ 4 is respectively as shown in SEQ ID NO.1 ~ 4.
2. the Primer composition of ox citrullinemia deleterious gene detection according to claim 1, it is characterized in that, described ox citrullinemia deleterious gene is the gene of the 86th amino acid codes generation nonsense mutation of argininosuccinate synthase gene.
3. the Primer composition of ox citrullinemia deleterious gene detection according to claim 1, it is characterized in that, the mol ratio of primer 1 and primer 2 is 1: 1, and the mol ratio of primer 3 and primer 4 is 1: 1.
4. a test kit for the Primer composition containing the arbitrary described ox citrullinemia deleterious gene detection of claims 1 to 3, is characterized in that, also include following component: archaeal dna polymerase, PCR reaction buffer, dNTP and aqua sterilisa.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310708022.9A CN103740816B (en) | 2013-12-20 | 2013-12-20 | The Primer composition that a kind of ox citrullinemia deleterious gene detects and test kit thereof and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310708022.9A CN103740816B (en) | 2013-12-20 | 2013-12-20 | The Primer composition that a kind of ox citrullinemia deleterious gene detects and test kit thereof and application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103740816A CN103740816A (en) | 2014-04-23 |
CN103740816B true CN103740816B (en) | 2015-07-29 |
Family
ID=50497881
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310708022.9A Expired - Fee Related CN103740816B (en) | 2013-12-20 | 2013-12-20 | The Primer composition that a kind of ox citrullinemia deleterious gene detects and test kit thereof and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103740816B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1952175A (en) * | 2006-10-23 | 2007-04-25 | 山东奥克斯生物技术有限公司 | Method and kit for detecting Chinese hosteln citrullinemia gene |
CN101265504A (en) * | 2008-03-17 | 2008-09-17 | 中国农业大学 | Kit for screening cattle citrullinemia carrier |
CN102181529A (en) * | 2011-03-04 | 2011-09-14 | 中国农业大学 | Method for detecting deleterious genes of bovine citrullinemia and special primers thereof |
-
2013
- 2013-12-20 CN CN201310708022.9A patent/CN103740816B/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1952175A (en) * | 2006-10-23 | 2007-04-25 | 山东奥克斯生物技术有限公司 | Method and kit for detecting Chinese hosteln citrullinemia gene |
CN101265504A (en) * | 2008-03-17 | 2008-09-17 | 中国农业大学 | Kit for screening cattle citrullinemia carrier |
CN102181529A (en) * | 2011-03-04 | 2011-09-14 | 中国农业大学 | Method for detecting deleterious genes of bovine citrullinemia and special primers thereof |
Non-Patent Citations (1)
Title |
---|
荷斯坦奶牛CN和DUMPS遗传缺陷病的巢式PCR检测方法的建立和应用;代元元 等;《中国动物检疫》;20140131;第31卷(第1期);76-85 * |
Also Published As
Publication number | Publication date |
---|---|
CN103740816A (en) | 2014-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103436631B (en) | A kind of test kit and method detecting CYP3A5 gene pleiomorphism | |
CN101921834A (en) | Polymerase chain reaction-sequence based typing (PCR-SBT) method for ABO blood type genotyping and reagent | |
CN104862419B (en) | A kind of primer, probe and kit for detecting infectious bovine rhinotrachetis virus | |
CN105087756A (en) | Method and kit for non-invasive measurement on fetus deaf pathogenic gene mutation | |
CN102010894B (en) | Nucleotide sequence, method and kit for detecting exons 12, 13 mutation of human K-ras gene | |
CN112176076B (en) | NFAT5 gene molecular marker related to goat growth traits and application thereof | |
CN104404164A (en) | Hereditary deafness gene mutation detection kit | |
CN103725796A (en) | BVDV (bovine viral diarrhea virus) internal control typing fluorescent PCR (polymerase chain reaction) detection kit and preparation thereof | |
Wu et al. | Whole-genome resequencing identifies KIT new alleles that affect coat color phenotypes in pigs | |
CN103290123B (en) | Detecting method and kit of cattle IGF2 (Insulin-like Growth Factor 2) gene mononucleotide polymorphism | |
CN107227371A (en) | Primer, molecular beacon, kit and its detection method of CYP2C9*3 gene pleiomorphism quick detections | |
CN105420393A (en) | Primers, probe, and kit for detecting BRCA1 gene expression | |
CN101392254B (en) | Clone of molecular marker relating to pig immune trait and uses thereof | |
CN103627804B (en) | Primer composition for detecting harmful gene of deficiency of uridine monophosphate synthase of cattle, kit with primer composition and application of kit | |
CN103740816B (en) | The Primer composition that a kind of ox citrullinemia deleterious gene detects and test kit thereof and application | |
CN101705306A (en) | Method for detecting bovine uridine monophosphate synthase deficiency disease by using AS-PCR | |
CN103571959B (en) | Primer, probe and kit for detecting gene locus mutation, and using methods | |
CN101265504B (en) | Kit for screening cattle citrullinemia carrier | |
CN103627803B (en) | Primer composition for detecting harmful gene of cattle blood coagulation factor XI deficiency, kit with primer composition and application of kit | |
CN109251972A (en) | CYP3A5*3 genotype quick detection kit based on POCT mode | |
CN103710443A (en) | Detection primer set, detection kit and detection method of related SNP (single-nucleotide polymorphism) for causing CVM (complex vertebral malformation) | |
CN102796819A (en) | Kit for detecting microdeletion of Y chromosome | |
CN102732625B (en) | Bovine leukocyte adhesion deficiency (BLAD) pyrosequencing detection method | |
CN102329885A (en) | Kit for detecting polymorphism of VKORC1 and CYP2C9 genes | |
CN106065416A (en) | A kind of detect the Specific PCR primers of cattle HCD carrier, test kit and detection method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150729 |